SEC Form 3 · accession 0001185185-18-001243
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rohit Goel
Officer — Manager & PAO
Period of report
May 9, 2018
Accepted (ET)
Jul 12, 2018 · 11:27 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | holding | — | — | — | 100,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F150,000 shares vest on September 30, 2018, and 50,000 shares vest on September 30, 2019.